AI trade rotation hits chipmakers as the Fed turns hawkish

Research and idea generation for personal use. Not investment advice. See full disclaimer at the bottom.

Top of mind

South Korea's Kospi swung from a technical bear market to a 4%+ rebound in a single session as AI-trade money rotates out of Korean and Taiwanese chipmakers into Chinese megacaps like Alibaba, even as US chip names had their own choppier week. That rotation lands the same week the Fed's June minutes revealed a genuine hawkish pivot — nine of 18 officials now pencil in a 2026 hike, versus zero in March — and a second day of US strikes on Iran keeps an oil risk premium in the tape. The obvious risk is a hawkish Fed and rising oil reinforcing each other into higher inflation expectations; the less obvious one is that a rotation trade moving this fast can reverse just as quickly if the flows into Chinese tech stall.

Market snapshot

(S&P, Nasdaq, and Dow levels are Wednesday, July 8 confirmed closes — the most recent complete session as of this report. 10Y is Wednesday's close. VIX and WTI are Thursday intraday reads. Sources: CNBC, Yahoo Finance, Federal Reserve H.15, FXDailyReport, TradingKey.)

Asset	Level	Change	Notes
S&P 500	7,482.71	-0.28%	Wednesday close; hawkish Fed minutes offset by moderating oil into the close
Nasdaq Composite	25,870.65	+0.20%	Wednesday close; eked out a gain despite a rough week for US chip names
Dow Jones	52,348.39	-1.09%	Wednesday close; worst of the three on Iran-driven risk-off flows
10Y Treasury	4.56%	+6bp	Wednesday close; hawkish FOMC minutes pushed yields higher on the day
VIX	~17.6	rising	Thursday intraday (opened 16.55, ranged as high as 18.91); second straight session higher
WTI Crude	~$74.20	little changed	Thursday intraday; holding most of this week's Iran-driven gains

Read-through: Wednesday's headline index moves undersold what's happening beneath the surface — money is leaving the AI trade's chip-stock epicenter for the trade's other beneficiaries (Chinese megacaps, custom-silicon plays) rather than leaving the AI trade altogether. That rotation, not the index-level print, is the more important signal today.

Headlines & analysis

1. AI-trade money rotates from Asian chipmakers into Chinese megacaps

Source: Bloomberg; Yahoo Finance; TradingKey So what: South Korea's Kospi, a bellwether for the chip-and-AI trade, fell as much as 20% from its recent peak into a technical bear market before rebounding more than 4% Thursday as SK Hynix (+8%) and Samsung Electronics (+4%) jumped alongside a broader chip bounce. At the same time, Alibaba has rallied roughly 9-12% over two sessions on pre-earnings optimism about narrowing losses in its instant-commerce business, with Baidu (+3%) and JD.com (+5%) following and the Hang Seng China Enterprises Index posting its biggest advance since April 2025. The move reads less like AI enthusiasm cooling and more like investors reshuffling which AI-adjacent names carry the least stretched valuation.

2. June FOMC minutes confirm a hawkish pivot under Chair Warsh

Source: CNBC; TechTimes; Yahoo Finance So what: Wednesday's minutes showed the committee's dot plot flipped from zero officials penciling in a 2026 hike as of March to nine of 18 doing so in June, with six of those nine projecting two 25-basis-point hikes. Warsh withheld his own dot and delivered a roughly 130-word statement, but the minutes make clear the substance behind his deliberately quiet communication style is genuinely hawkish — the 10-year yield rose 6bp to 4.56% on the release.

3. A second day of US strikes on Iran keeps an oil risk premium in the tape

Source: Al Jazeera; CNBC So what: President Trump said the US-Iran ceasefire is "over" after tanker attacks in the Strait of Hormuz, and Treasury revoked the license that had allowed Iran to export oil, sending Brent up roughly 5% to near $78 Wednesday. WTI is holding most of that move Thursday, trading near $74. Roughly a fifth of global oil transits the strait, so further attacks or a retaliation/de-escalation signal is the key swing factor for where energy and inflation-sensitive assets go next.

4. US chip stocks lag their Asian counterparts even as the AI story stays intact

Source: 24/7 Wall St.; Yahoo Finance So what: While Korean and Taiwanese chip names rebounded Thursday, Broadcom, AMD, Micron, KLA, and Marvell all traded lower into midweek — Broadcom slipped on a valuation-driven analyst downgrade Tuesday before rebounding almost 5% Wednesday on a new $30 billion, multi-year custom-chip agreement with Apple running through 2031. The divergence between the Asian rebound and a choppier domestic chip complex is a reminder that "the AI trade" is no longer one trade — it's several, with money moving between them on different timelines.

5. PepsiCo reports Q2 before today's open with Frito-Lay volume the swing factor

Source: TradingKey; Benzinga; Alphastreet So what: Consensus calls for $2.21 EPS on roughly $23.9-24.0B in revenue. PepsiCo has beaten EPS estimates in each of its last four quarters, but the stock is up just 1% year-to-date versus the S&P 500's high-single-digit gain, and options markets were pricing in a roughly 4.5% post-earnings move. The number that matters more than the EPS beat/miss is whether North American snack volumes show a second straight quarter of improvement after Q1's roughly 2% growth.

Ideas — long-term core

Quality businesses, durable competitive advantages, reasonable valuation. Hold horizon: years.

AVGO — Broadcom

• Thesis: Broadcom's combination of custom AI silicon (its XPU business) and networking gear has made it one of the few companies capturing AI-infrastructure spend outside Nvidia, reinforced this week by a new multi-year, $30B+ custom-chip agreement with Apple running through 2031.
• Valuation note: Shares trade near $368, roughly 62x trailing earnings — rich even against the sector's elevated multiples and above Broadcom's own historical average. This is a pay-up-for-quality setup, not a value entry.
• Why now (or why patient): Q3 AI semiconductor guidance of ~$16B came in slightly below the ~$16.4B analysts wanted, and the stock has swung within the week (down on the valuation-driven downgrade Tuesday, up almost 5% Wednesday on the Apple news). Dollar-cost into weakness makes more sense than chasing strength at these multiples.
• Risks / bear case: At 62x earnings, any deceleration in AI capex or a guidance miss versus Street numbers — which already happened once this quarter — can produce an outsized drawdown. Broadcom is also a direct beneficiary of the same AI-trade sentiment currently rotating toward Chinese tech; a sustained rotation away from US chip names is a real risk to the multiple, independent of the underlying business.

GILD — Gilead Sciences

• Thesis: A durable HIV franchise, where long-acting therapies are improving patient adherence, combined with emerging oncology catalysts (Trodelvy's recent first-line cancer approval), gives Gilead multiple growth vectors as its legacy dolutegravir-era HIV business faces generic competition.
• Valuation note: HSBC upgraded the stock to Buy on July 6, raising its price target to $155 from $133, and pegged the valuation at roughly 13x next year's expected earnings — cheap for a franchise HSBC models growing revenue 5.8% annually through the decade.
• Why now (or why patient): The stock is already up (+5.35% on July 7) on the upgrade and the Trodelvy approval, so some good news is priced in short-term — but the valuation re-rating case is a multi-quarter thesis, not a one-day trade.
• Risks / bear case: HSBC's own framing concedes the market's central worry — that generic dolutegravir competition erodes the HIV franchise faster than modeled. If long-acting therapy adoption disappoints, the "consensus is too pessimistic" argument breaks down along with the valuation case.

Ideas — opportunistic

Catalyst-driven, time-bound, sized smaller. Hold horizon: days to months. Define exit before entry.

PEP — post-earnings volatility setup

• Catalyst: Q2 results released before today's open; options markets priced in a roughly 4.5% move.
• Time horizon: Today's session through the next few days as the market digests the Frito-Lay volume trend.
• What would invalidate: A miss on North American snack volumes or another guidance cut on the recovery timeline — that's the specific number that matters more than the EPS beat/miss.
• Risk note: This is an earnings-reaction trade, not a re-rating call. Pepsi is trading near 52-week lows for a reason (soft North American snacking); don't mistake a one-day pop for a resolved thesis.

XOM — Strait of Hormuz risk-premium trade

• Catalyst: A second consecutive day of US strikes on Iran, "the ceasefire is over" comments from President Trump, and Treasury's revocation of Iran's oil-export license, which drove Brent up roughly 5% Wednesday.
• Time horizon: Days, contingent on whether Iran retaliates further or a de-escalation signal emerges.
• What would invalidate: A ceasefire or de-escalation that lets WTI give back its recent gains toward the high-$60s/low-$70s would remove the premium driving the trade.
• Risk note: This is a headline-driven trade that can reverse overnight on a single event you can't front-run. Size for a round trip, not a one-way move.

Portfolio-level guidance

Allocation and risk observations. Not specific buy/sell calls — those depend on a full picture this report doesn't see.

• Concentration check: This week's AI-trade leadership rotation — Kospi in a technical bear market one day, rebounding sharply the next, money flowing toward Chinese megacaps — is a reminder that "AI exposure" isn't one trade. A portfolio concentrated in US chip names specifically has behaved differently this week than broader AI-adjacent exposure (Chinese tech, custom-silicon plays like Broadcom's Apple deal).

• Rates positioning: Wednesday's Fed minutes were a genuine hawkish surprise — zero of 18 hike dots in March to nine of 18 in June. Dallas Fed President Logan and FOMC voter Williams both speak today, the first Fed commentary since the minutes; worth watching whether either reinforces or pushes back on that hawkish read before adjusting rate-sensitive positioning.

• Cash & dry powder: Three live catalysts land within about 24 hours of each other — PepsiCo's print this morning, two Fed speakers today, and Delta's earnings tomorrow — on top of the still-unresolved Iran situation. Letting the initial reaction to each settle before trading it is the more disciplined path.

• Risk regime read: VIX has risen for a second straight session (from ~16.1 Wednesday intraday to as high as 18.91 Thursday) even as headline index moves stay modest. That rising trend, on actual geopolitical and policy catalysts rather than drift, is more informative than the still-low absolute level.

Watch list — tomorrow / this week

Earnings: PepsiCo reported before today's open (consensus $2.21 EPS on ~$23.9-24.0B revenue). Delta Air Lines reports tomorrow, Friday, July 10, with a webcast around 10:00 a.m. ET; management previously guided to roughly $1 billion in June-quarter pretax profit.

Economic data: Initial jobless claims (8:30 a.m. ET, consensus ~218K) and existing home sales (consensus ~4.19M) are both due today. June CPI is the next major print, out Tuesday, July 14.

Fed / central bank: FOMC voter John Williams speaks at 9:00 a.m. ET and Dallas Fed President Lorie Logan at 1:30 p.m. ET today — the first Fed commentary since Wednesday's hawkish June minutes. The next FOMC decision is July 29.

Other: Watch for further Iranian retaliation or a de-escalation signal in the Strait of Hormuz. Separately, watch whether Thursday's Kospi rebound holds or the rotation toward Chinese megacaps continues — that's the more structural story for AI-exposed portfolios this week.

Disclaimer

This report is prepared for personal research and informational purposes only. It does not constitute investment advice, an offer, or a solicitation to buy or sell any security. Information is drawn from public sources believed to be reliable but is not guaranteed accurate or complete. Markets change rapidly; data may be stale by the time of reading. Any "ideas" mentioned are research candidates, not recommendations, and do not consider any specific person's financial situation, objectives, or risk tolerance. Consult a licensed financial advisor before making investment decisions. Past performance does not predict future results.